Prospective Use of Philips iSuite for Interventional Procedures
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 3/8/2019 |
| Start Date: | April 1, 2019 |
| End Date: | March 2021 |
| Contact: | Connie Sathre, CCRP |
| Email: | sathre@mayo.edu |
| Phone: | 507-538-0540 |
This research study is being done to look at new MRI imaging guidance software, Philips
Interventional iSuite software, to see if using will improve the physician's ability to
quickly place and guide needle tip position for biopsies and ablations.
Interventional iSuite software, to see if using will improve the physician's ability to
quickly place and guide needle tip position for biopsies and ablations.
The purpose of this study is to evaluate Philips Interventional iSuite software used for MRI
guided procedures in the MRI suite. The real-time MRI Imaging software will be used during an
MRI procedure to take continuous pictures.
The Philips Interventional iSuite software package has not received FDA 510(k) clearance. The
Investigator will be evaluating and publishing on the use of this software as a clinical aid
in performing interventional procedures within the MR suite. The primary evaluation will be
weighted toward enhanced facilitation of ablation procedures. However, the software will not
replace standard MR imaging for final confirmation of needle tip position and ablation
margins.
guided procedures in the MRI suite. The real-time MRI Imaging software will be used during an
MRI procedure to take continuous pictures.
The Philips Interventional iSuite software package has not received FDA 510(k) clearance. The
Investigator will be evaluating and publishing on the use of this software as a clinical aid
in performing interventional procedures within the MR suite. The primary evaluation will be
weighted toward enhanced facilitation of ablation procedures. However, the software will not
replace standard MR imaging for final confirmation of needle tip position and ablation
margins.
Inclusion criteria:
- Patients already scheduled for a percutaneous MR guided procedure
Exclusion criteria:
- Pregnant Women
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: David A. Woodrum, M.D., Ph.D.
Phone: 507-538-0540
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
